Myeloma | Tumor

Ninlaro Found to Be Effective and Safe for Treatment of Newly Diagnosed Multiple Myeloma

August 28th 2020, 1:00pm


In addition to improving progression-free survival, researchers have found single-agent Ninlaro (ixazomib) to be a tolerable option in patients with newly diagnosed multiple myeloma who have also already undergone an autologous stem cell transplant.

Learning About Resources in Multiple Myeloma

August 26th 2020, 9:00pm


On behalf of the Multiple Myeloma Research Foundation, CURE spoke with five specialists to offer various resources for patients with multiple myeloma.

FDA Approves Kyprolis in Combination with Darzalex and Dexamethasone for Relapsed/Refractory Multiple Myeloma

August 20th 2020, 11:35pm


The Food and Drug Administration (FDA) has approved the expansion of Kyprolis (carfilzomib) in combination to with Darzalex (daratumumab) plus dexamethasone in once- and twice-weekly dosing regimens for the treatment of patients with relapsed or refractory multiple myeloma who have received a maximum of three prior lines of therapy.

More Effective Treatment Options are Needed for Patients with Advanced Multiple Myeloma

August 20th 2020, 6:00pm


Despite recent advances in the treatment of multiple myeloma, more must be done to find effective treatment options for patients with advanced disease, according to Dr. Luciano J. Costa.

Clinical Trials Are Pivotal in the Evolution of CAR-T Cell Therapy in Multiple Myeloma

August 18th 2020, 9:24pm


While the use of CAR-T cell therapy is currently still being investigated in patients with multiple myeloma, Dr. Nina Shah of the UCSF Helen Diller Family Comprehensive Cancer Center believes that these clinical trials will be what ultimately moves the field forward.

An Expert Discusses the Future of Multiple Myeloma Treatments

August 18th 2020, 6:15pm


The future of multiple myeloma is heading toward combination therapies and CAR-T cell treatments, according to Dr. Betsy O'Donnell.

What Do You Do to Pamper Yourself During or After Cancer Treatment?

August 17th 2020, 6:00pm


On social media, CURE® recently asked its readers to share how they pamper and treat themselves during or after their cancer treatment. Here, we share some of their responses.

FDA Approves Blenrep to Treat Relapsed/Refractory Multiple Myeloma

August 6th 2020, 5:56am


The Food and Drug Administration approved Blenrep to treat patients with relapsed/refractory multiple myeloma.

What Advice Would You Give Someone Looking to Help A Friend or Loved One with Cancer?

August 4th 2020, 1:00am


On social media, CURE® recently asked its readers to share the advice they would give someone looking to help a friend or loved one with cancer. Here, we share some of their responses.

Minimal Residual Disease is A Vital Marker for Patients with Multiple Myeloma, Says Expert

July 31st 2020, 10:03pm


Dr. Parameswaran Hari discusses the importance of understanding a patient’s MRD if they are receiving the maintenance therapy Sarclisa for multiple myeloma.